Treatment of Obese Binge Eater Jung Hyun Lee, M.D. Treatment of Obese Binge Eater Email : docljh@empal.com Abstract It is now widely recognized that there is a subgroup of obese individuals with a significantly disordered eating behavior characterized by binge eating and psychosocial impairment. Many therapeutic approaches for the treatment of obese binge eaters including cognitivebehavioral therapy, treatment of obesity, nutritional counseling, psychoeducation, psychotherapy, motivation enhancement therapy, and medication have their own benefits. Treatment programs for obesity and eating disorders (binge eater, bulimia) have tended to adopt very different approaches to the eating behavior (dieting vs cessation of dieting) and body image (weight loss vs accepting one's current weight). Despite these differences, eating disorders, obesity, and unhealthy weight loss practices have a number of shared personal, socioenvironmental, and behavioral problems. It is important to integrate the treatment approaches to the spectrum of problems related to eating and weight (eating disorders, obesity, and unhealthy weight loss practices). Keywords : Binge eating; Obesity; Integration 309
310
311
312
11. Lori MI, Dianne NS. Integrating of prevention of eating disor- and obesity : feasible or futile? Preventive Medicine 2002 ; der 34 : 299-309 12. Stunkard AJ. Eating patters and obesity. Psychiatr Q 1959 ; 33 : 284-92 13. Spitzer RL, Devlin MJ, Walsh BT, Hasin D, Wing RR, Nonas C, et al. Binge eating disorder : A multisite field trial for the diagnostic criteria. Int J Eat Disord 1992 ; 11 : 191-203 14. Mitchell JE, Raymond NC, Spitzer RL. Binge eating disorder : Clinical features and treatment of a new diagnosis. Harvard Rev Psychiatry 1994 : 310-25 15. Yanovski SZ, Spitzer RL. Binge eating disorder is associated with psychiatric comorbidity in the obese. Am J Psychiatry 1993 ; 150 : 1472-9 16. Marcus MD. Binge eating and obesity. In eating disorders and obesity. Brownell KD, Fairburn CG, ed. New York : The Guilford Press, 1995 : 441-4 17. Garner DM, Olmsted MP, Davis R, Rockert W, Goldbloom D, Eagle M. The association between bulimic symptoms and reported psychopathology. Int J Eat isord 1990 ; 9 : 1-15 313
18. Ranson KM, Kaye WH, Weltzin TE, Rao R, Matsunaga H. Obsessivecompulsive disorder symptoms before and after recovery from bulimia nervosa. Am J Psychiatry 1999 ; 156 : 1703-8 19. Anderson AE, Bowers W, Watson T. A slimming program for ED NOS : Reconceptualizing a confusing residual diagnosis category. Psychiatr Clin North Am (in press) 10. Robin FA, Agras WS. Overcoming eating disorders : A cognitivebehavioral treatment for bulimia nervosa and binge eating disorder, 1998 : 1-20 11. Wiiliam RM, Stephen R. Motivational interviewing : Preparing people for change. 2nd ed. New York : The Guilford Press, 2002 : 201-6 12. Agras WS, Scott JC, Katherine AH, James EM, Terence WG, Helena CK. Outcome predictors for the cognitie behavioral treatment of bulimia nervosa : data from a multisite study. Am J Psychiatry 2000 ; 157 : 1302-8 13. Fairburn CG, Kirk J, O Connor M. A comparison of two psychological treatment for bulimia nervosa. Behav Res Ther 1986 ; 24 : 629-43 14. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa : a multicenter, placebocontrolled, doubleblind trial. Arch Gen Psychiatry 1992 ; 49 : 139-47 15. Susan LM, Leah SC, Eric BN, Kathleen AL, Cesar AS, James IH, et al. Placebocontrolled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry 2000 ; 157 : 1004-6 16. James IH, Susan LM, Nancy CR, Scott C, Paul EK, Jeffrey MJ, et al. Fluvoxamine in the treatment of bingeeating disorder : A multicenter placebocontrolled doubleblind trial. Am J Psychiatry 1998 ; 155 : 1756-62 17. Alexander N, Andrea W, Cicek W. Addition of naltrexone to fluoxetine in the treatment of binge eating disorder. Am J Psychiatry 1999 ; 156 : 797 18. Steven JR, Katherin AH, Neena PS, Stephanie CK, Jalia SL. A placebocontrolled study of fluoxetine in controlled treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry 2002 ; 159 : 96-102 314